Delivery to macrophages and toxic action of etoposide carried in mouse red blood cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1620, Issue 1-3, 2003, Pages 160-166

  Lotero, L Alfredo ^a   Olmos, Gemma ^a   Diez, José C ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Band 3 protein; Carrier erythrocyte; Crosslinking; Diamide; Etoposide; Macrophage; Mouse; Phagocytosis

Indexed keywords

ANTINEOPLASTIC AGENT; DNA FRAGMENT; ETOPOSIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COMPARTMENTALIZATION; CELL ENCAPSULATION; CELL MEMBRANE; CHEMICAL MODIFICATION; CHEMICAL PARAMETERS; CONTROLLED STUDY; CROSS LINKING; CULTURE MEDIUM; CYTOPLASM; ERYTHROCYTE; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; TOXICITY;

EID: 0037451745     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(02)00536-6     Document Type: Article

References (36)

1. DeLoach J.R. Carrier erythrocytes. Med. Res. Rev. 6:1986;487-504.
2. Zocchi E., Tonetti M., Polvani C., Guida L., Benatti U., DeFlora A. Encapsulation of doxorubicin in liver-targeted erythrocytes increases the therapeutic index of the drug in a murine metastatic model. Proc. Natl. Acad. Sci. U. S. A. 86:1989;2040-2044.
3. Talwar N., Jain N.K. Erythrocyte based delivery of primaquine: in vitro characterization. J. Microencapsul. 9:1992;357-364.
4. Ropars C., Avenard G., Chassaigne M. Large-scale entrapment of drugs into resealed red blood cells using a continuous flow-dialysis system. Methods Enzymol. 140:1987;242-248.
5. Tonetti M., De Flora A. Carrier erythrocytes. Clinical pharmacokinetic considerations. Clin. Pharmacokinet. 25:1993;351-357.
6. DeLoach J.R., Droleskey R.E. Survival of murine carrier erythrocytes injected via peritoneum. Comp. Biochem. Physiol., A. 84:1986;441-445.
7. DeLoach J.R., Andrews K., Sheffield C.L. Encapsulation of interleukin-2 in murine erythrocytes and subsequent deposition in mice receiving a subcutaneous injection. Biotechnol. Appl. Biochem. 10:1988;183-190.
8. Bellelli A., Benedetti P.L., Coletta M., Ippoliti R., Brunori M. Human erythrocytes cross-linked with glutaraldehyde: general properties and significance as a blood substitute. Biochem. Biophys. Res. Commun. 156:1988;970-977.
9. Zocchi E., Tonetti M., Polvani C., Guida L., Benatti U., DeFlora A. In vivo and lung targeting of adriamycin encapsulated in glutaraldehyde-treated murine erythrocytes. Biotechnol. Appl. Biochem. 10:1988;555-562.
10. Magnani M., Rossi L., Brandi G., Schiavano G.F., Montroni M., Piedimonte G. Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies. Proc. Natl. Acad. Sci. U. S. A. 89:1992;6477-6481.
11. Jordán J.A., DeLoach J.R., Luque J., Diez J.C. Targeting of mouse erythrocytes by band 3 crosslinkers. Biochim. Biophys. Acta. 1291:1996;27-34.
12. Jordán J.A., Alvarez F.J., Tejedor M.C., Diez J.C. Band 3 crosslinking - induced targeting of mouse carrier erythrocytes. Biotechnol. Appl. Biochem. 29:1999;59-65.
13. Jordán J.A., Alvarez F.J., Lotero L.A., Olmos G., Calleja P., Tejedor M.C., Diez J.C. Differential induction of macrophage recognition of carrier erythrocytes by treatment with band 3 cross-linkers. Biotechnol. Appl. Biochem. 27:1998;133-137.
14. Alvarez F.J., Jordán J.A., Calleja P., Lotero L.A., Olmos G., Diez J.C., Tejedor M.C. Cross-linking treatment of loaded erythrocytes increases delivery of encapsulated substance to macrophages. Biotechnol. Appl. Biochem. 27:1998;139-143.
15. Olmos G., Lotero L.A., Tejedor M.C., Diez J.C. Delivery to macrophages of Interleukin 3 loaded in mouse erythrocytes. Biosci. Rep. 20:2000;399-410.
16. Magnani M., Casabianca A., Fraternale A., Brandi G., Gessani S., Williams R., Giovine M., Damonte G., DeFlora A., Benatti U. Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection. Proc. Natl. Acad. Sci. U. S. A. 93:1996;4403-4408.
17. Magnani M., Rossi L., D'Ascenzo M., Panzani I., Bigi L., Zanella A. Erythrocyte engineering for drug delivery and targeting. Biotechnol. Appl. Biochem. 28:1998;1-6.
18. Crinelli R., Antonelli A., Bianchi M., Gentilini L., Scaramucci S., Magnani M. Selective inhibition of NF-κB activation and TNF-α production in macrophages by red blood cell-mediated delivery of dexamethasone. Blood Cells Mol. Diseases. 26:2000;211-222.
19. Rossi L., Serafini S., Cenerini L., Picardi F., Bigi L., Panzani I., Magnani M. Erythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease. Biotechnol. Appl. Biochem. 33:2000;85-89.
20. 3+ and diamide oxidised erythrocytes. Biosci. Rep. 21:2001;857-871.
21. Ranjan P., Sodhi A., Srivastava A. Cisplatin and interferon-γ treated murine macrophages induce apoptosis in tumor cell lines. Anti-Cancer Drugs. 8:1997;797-806.
22. 9-Tetrahidrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspases-1. J. Pharmacol. Exp. Ther. 286:1998;1103-1109.
23. von Knethen A., Lotero L.A., Brüne B. Etoposide and cisplatin induced apoptosis in activated RAW 264.7 macrophages is attenuated by cAMP-induced gene expression. Oncogene. 17:1998;387-394.
24. Ranjan P., Sodhi A., Singh S.M. Murine peritoneal macrophages treated with cisplatin and interferon-γ undergo NO-mediates apoptosis via activation of an endonuclease. Anti-Cancer Drugs. 9:1998;333-341.
25. Liu L.F. DNA topoisomerase poisons as anti-tumour drugs. Annu. Rev. Biochem. 58:1989;351-375.
26. Wang H., Mao Y., Zhou N., Hu T., Hsieh T.S., Liu L.F. ATP-bound topoisomerase II as a target for anti-tumour drugs. J. Biol. Chem. 276:2001;15990-15995.
27. Sebestyén A., Mihalik R., Peták I., Kopper L. Modulation of apoptosis signaling in etoposide treated-lymphoma cells. Anticancer Res. 17:1997;2609-2614.
28. Chiarantini L., Johnson J., DeLoach J.R. Optimized recirculation survival of mouse carrier erythrocytes. Blood Cells. 17:1991;607-617.
29. Tejedor M.C., Alvarez C.E., Alvarez F.J., Herráez A., Luque J. Comparative dialysis encapsulation at different hypotonic pressures in human and rat erythrocytes. Adv. Biosci. 92:1994;73-82.
30. Alvarez F.J., Herráez A., Tejedor M.C., Diez J.C. Behaviour of isolated rat and human red blood cells upon hypotonic-dialysis encapsulation of carbonic anhydrase and dextran. Biotechnol. Appl. Biochem. 23:1996;173-179.
31. Jordán J.A., Alvarez F.J., Lotero L.A., Herráez A., Diez J.C., Tejedor M.C. In vitro phagocytosis of carrier mouse red blood cells is increased by Band 3 cross-linking or diamide treatment. Biotechnol. Appl. Biochem. 34:2001;143-149.
32. 2+ concentration. Arch. Biochem. Biophys. 269:1989;365-370.
33. Glockzin S., von Knethen A., Scheffner M., Brune B. Activation of the cell death program by nitric oxide involves inhibition of the proteosome. J. Biol. Chem. 274:1999;19581-19586.
34. Biber J., Jabbour S., Parihar R., Dierksheide J., Hu Y., Baumann H., Bouchard P., Cligiur M., Carson W. Administration of two macrophage-derived interferon-gamma-inducing factors (IL-12 and IL-15) induces a lethal systemic inflammatory response in mice that is dependent on natural killer cells but does not require interferon-gamma. Cell. Immunol. 216:2002;31.
35. Raso G.M., Pacilio M., Esposito E., Coppola A., Di Carlo R., Meli R. Leptin potentiates IFN-gamma-induced expression of nitric oxide synthase and cyclo-oxygenase-2 in murine macrophage J774A.1. Br. J. Pharmacol. 137:2002;799-804.
36. Falcao P.L., Correa-Oliveira R., Fraga L.A., Talvani A., Proudfoot A.E., Wells T.N., Williams T.J., Jose P.J., Teixeira M.M. Plasma concentrations and role of macrophage inflammatory protein-1-alpha during chronic schistosoma mansoni infection in humans. J. Infect. Dis. 186:2002;1696-1700.